Advanced breast cancer: an update and controversies on diagnosis and therapy

被引:10
作者
Nicolini, A
Cupi, A
机构
[1] Univ Pisa, Dept Internal Med, I-56126 Pisa, Italy
[2] Univ Pisa, Dept Reprod & Aging, Pisa, Italy
关键词
advanced breast cancer;
D O I
10.1016/j.biopha.2003.09.003
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
This review on advanced breast cancer considered important differences in the actual definition of this condition. Advanced breast cancer includes locally advanced, locoregionally recurrent and metastatic disease, which have different diagnosis, prognosis and therapy; their actual definitions are relatively uncertain. Differently from the common opinion that metastatic breast cancer (MBC) is a very severe incurable disease, recently it has been reported that a small but not irrelevant fraction of MBC patients can be cured or remain in long-term survival with complete remission. The type of metastases of the population studied in these reports was analysed and the authors hypothesised that the particularly high DFS reported mainly was attributable to the high proportion of patients with locoregional metastases only. Furthermore, the options and associations of the drug therapy available for treatment of advanced breast cancer have been reviewed. (C) 2003 Editions scientifiques et medicales Elsevier SAS. All rights reserved.
引用
收藏
页码:439 / 446
页数:8
相关论文
共 80 条
[1]  
[Anonymous], 1986, J Clin Oncol, V4, P186
[2]   Hormonal therapy prolongs survival in irradiated locally advanced breast cancer: A European organization for research and treatment of cancer randomized phase III trial [J].
Bartelink, H ;
Rubens, RD ;
vanderSchueren, E ;
Sylvester, R .
JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (01) :207-215
[3]  
Blum JL, 2001, CANCER, V92, P1759, DOI 10.1002/1097-0142(20011001)92:7<1759::AID-CNCR1691>3.0.CO
[4]  
2-A
[5]  
Boissier S, 2000, CANCER RES, V60, P2949
[6]   Primary chemotherapy in operable breast cancer: Eight-year experience at the Milan Cancer Institute [J].
Bonadonna, G ;
Valagussa, P ;
Brambilla, C ;
Ferrari, L ;
Moliterni, A ;
Terenziani, M ;
Zambetti, M .
JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (01) :93-100
[7]   Anastrozole versus tamoxifen as first-line therapy for advanced breast cancer in 668 postmenopausal women:: Results of the tamoxifen or arimidex randomized group efficacy and tolerability study [J].
Bonneterre, J ;
Thürlimann, B ;
Robertson, JFR ;
Krzakowski, M ;
Mauriac, L ;
Koralewski, P ;
Vergote, I ;
Webster, A ;
Steinberg, M ;
von Euler, M .
JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (22) :3748-3757
[8]  
Bonneterre J, 2001, CANCER, V92, P2247, DOI 10.1002/1097-0142(20011101)92:9<2247::AID-CNCR1570>3.0.CO
[9]  
2-Y
[10]   FIRST ISOLATED LOCOREGIONAL RECURRENCE FOLLOWING MASTECTOMY FOR BREAST-CANCER - RESULTS OF A PHASE-III MULTICENTER STUDY COMPARING SYSTEMIC TREATMENT WITH OBSERVATION AFTER EXCISION AND RADIATION [J].
BORNER, M ;
BACCHI, M ;
GOLDHIRSCH, A ;
GREINER, R ;
HARDER, F ;
CASTIGLIONE, M ;
JUNGI, WF ;
THURLIMANN, B ;
CAVALLI, F ;
OBRECHT, JP ;
LEYVRAZ, S ;
ALBERTO, P ;
ADAM, H ;
VARINI, M ;
LOEHNERT, T ;
SENN, HJ ;
METZGER, U ;
BRUNNER, K .
JOURNAL OF CLINICAL ONCOLOGY, 1994, 12 (10) :2071-2077